香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 就 因 本 公 告 全部或任何部分內容所產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 YH Entertainment Group 樂華娛樂集團 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：2306） 正面盈利預告 本公告乃由 樂華娛樂集團（「本公司」，連 同 其 子 公 司 統 稱 為「本集團」）根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」）第13.09(2)(a)條及香港法例第 571章證券及期貨條例第XIVA部 項 下 的 內 幕 消 息 條 文（定 義 見 上 市 規 則）而 刊 發。 本 公 司 董 事（「董 事」）會（「董事會」）謹 此 知 會 本 公 司 股 東（「股 東」）及 本 公 司 潛 在 投 資 者，根 據 對 本 集 團 截 至2025年6月30日 止 六 個 月（「有關期間」）的 未 經 審 核 綜 合 管 理 賬 目 及 董 事 ...

Group 1 - The core issue highlighted is the growing tension between artists and their management companies, reflecting a crisis in the entertainment industry as companies struggle with resource allocation and support for artist development [3][4][7] - Many management companies are shifting their strategies to focus on signing younger artists to build a sustainable talent pipeline, recognizing the risks of relying solely on a few top artists [4][9] - The traditional model of artist management is becoming outdated, as companies face challenges in nurturing new talent due to increased production costs and a shrinking market for new projects [20][24] Group 2 - The departure of prominent artists from management companies can significantly impact the companies' revenues and overall business health, as seen with the cases of various artists leaving their agencies [7][10] - The entertainment industry is witnessing a shift towards direct collaborations between platforms and artists, bypassing traditional management companies, which diminishes the latter's role as resource intermediaries [22][24] - The industry's future may depend on companies evolving from resource controllers to value creators, fostering partnerships with artists that emphasize mutual growth and professional development [24][25]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年7月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 乐华娱乐集团 | | | | | | 呈交日期: | 2025年8月5日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 02306 | 說明 | | | | | | 法定/註冊股份數目 | 面值 | | 法定/註冊股本 | | | --- | --- | --- | --- | --- | --- | | 上月底結存 | | 2,000,000,000 USD | 0.0001 | USD | 200,000 | | 增加 / 減少 (-) | | 0 | | USD | 0 | | 本月底結存 | | 2,000,000,000 USD | 0 ...

以金额进行统计，7月21日回购金额最多的是中国东方航空股份，回购金额为851.94万港元；其次是蒙 牛乳业，回购金额为342.07万港元；回购金额居前的还有IGG、名创优品等。回购数量上看，7月21日 回购股数最多的是嬴集团，当日回购量为400.00万股；其次是中电光谷、中国东方航空股份等，回购数 量分别为400.00万股、294.40万股。 证券时报·数据宝统计显示，7月21日有18家香港上市公司进行了股份回购，合计回购1367.05万股，回购 金额2125.31万港元。 值得关注的是，本次回购851.94万港元的中国东方航空股份，年内则进行多次回购，合计回购金额为 5.84亿港元。（数据宝） 7月21日港股公司回购一览 | 代码 | 简称 | 回购股数 | 回购金额（万 | 回购最高价 | 回购最低价 | 年内累计回购金额 | | --- | --- | --- | --- | --- | --- | --- | | | | （万股） | 港元） | （港元） | （港元） | （万港元） | | 00670 | 中国东方航 空股份 | 294.40 | 851.94 | 2.910 | 2.850 | ...

Group 1 - The article reports on share buybacks conducted by various companies on July 21, 2025, with China Eastern Airlines leading in both the number of shares repurchased and the total amount spent [1][2] - China Eastern Airlines repurchased 2.944 million shares for a total of HKD 8.5194 million, representing 1.915% of its total share capital for the year [2] - Other notable companies involved in the buyback include Mengniu Dairy, IGG, and Vitasoy, with varying amounts and percentages of their total share capital repurchased [1][2] Group 2 - Mengniu Dairy repurchased 200,000 shares for HKD 3.4207 million, accounting for 0.127% of its total share capital [2] - IGG repurchased 490,000 shares for HKD 2.1160 million, which is 0.617% of its total share capital [2] - Vitasoy repurchased 56,000 shares for HKD 0.5186 million, representing 1.363% of its total share capital [2]

Core Viewpoint - The partnership between Lehua Entertainment and Huaxi Biological has ended, with Lehua's subsidiary Tianjin Yihua exiting the ownership of the children's skincare brand Runxihe, which was established to address the skincare needs of the founders' daughters [1] Group 1: Company Developments - Huaxi Biological announced the completion of the equity transfer on July 10, 2025, indicating a strategic shift away from the Runxihe brand [1] - The initial collaboration aimed to leverage the strengths of both companies in skincare active ingredients and cultural entertainment, but the operational outcomes did not align with the founders' original intentions [1] - Lehua Entertainment plans to refocus on its core business and IP development following the amicable separation [1] Group 2: Brand Status - Runxihe, which was launched in 2019, is still listed on Huaxi Biological's website as its only children's skincare brand, featuring products like cleansers, moisturizers, shower gels, lip balms, and hand creams [1] - The brand's official flagship store is no longer searchable on major e-commerce platforms like Tmall and JD, with products now primarily available through third-party sellers [1] - The collaboration initially aimed to utilize celebrity influence to boost brand visibility, but this strategy did not yield the expected growth for the children's skincare line [1]

Core Viewpoint - Lehua Entertainment has quietly exited its partnership with Huaxi Biological, with the latter announcing the withdrawal of Tianjin Yihua Management Consulting Co., Ltd. from the shareholder list of the children's skincare brand Runxihe, effective July 10, 2025. The collaboration was initially based on the founders' insights into their daughters' skincare needs, but the operational model did not meet expectations, prompting the decision to part ways [1][13]. Company Summary - Huaxi Biological's announcement highlighted that the original intention behind the Runxihe brand was to leverage the strengths of both companies in skincare active ingredients and cultural entertainment to create a children's skincare brand. However, the operational model failed to reflect the founders' original vision, leading to the decision to adjust the partnership [1][13]. - Lehua Entertainment confirmed its focus on core business development and IP expansion following the amicable agreement with Huaxi Biological. The company previously held a 50% stake in Runxihe [4][13]. - The Runxihe brand, launched in 2019, was part of a joint venture established in 2023, coinciding with Lehua Entertainment's IPO in Hong Kong. The brand aimed to tap into the beauty market, which was seen as a potential growth area for Lehua [16][17]. Industry Summary - The children's skincare segment has emerged as a lucrative area for domestic beauty brands, with several companies entering the market, including Betaini with "Winona Baby" and Shanghai Jahwa with "Qichu." The market has seen rapid growth, with brands like "Turtle Dad" and "Kangaroo Mom" gaining significant traction [18]. - Despite the initial promise, Runxihe's performance has not met expectations, as indicated by Huaxi Biological's recent quarterly reports, which did not mention the brand's performance or product lines. The company has been undergoing significant organizational changes since late 2022, which may have influenced the decision to exit the partnership [17][18].

Group 1 - The core point of the news is the strategic shift in the partnership between Huaxi Biological and Lehua Entertainment, with Lehua exiting the shareholder list of Beijing Runxihe Biotechnology Co., Ltd. and Huaxi increasing its stake to 100% [1][2] - Huaxi Biological and Lehua Entertainment have decided to adjust their existing cooperation model after reviewing past collaborations, believing that the previous model did not fully leverage the strengths of both leading companies in their respective industries [1][2] - The initial intention behind the establishment of the Runxihe brand was to address skincare needs for children, combining Huaxi's expertise in active skincare ingredients and Lehua's strengths in cultural entertainment [1][2] Group 2 - Huaxi Biological's subsidiary, Beijing Huaxi Haiyu Technology Co., Ltd., has completed the share transfer process with Tianjin Yihua Management Consulting Co., Ltd., which exited the Runxihe shareholder list on July 10, 2025 [2] - Runxihe is the only children's skincare brand under Huaxi Biological, which has established a significant market presence in skincare products, particularly leveraging its expertise in hyaluronic acid technology [2] - Lehua Entertainment, known for its talent management, has unique resources and advantages in brand marketing and communication, which were expected to complement Huaxi's strengths in the children's skincare market [2]

Group 1 - The article reports on stock buybacks conducted by various companies on July 15, 2025, with a total of 20 companies participating in the buyback program [1] - The company with the largest buyback amount was Wan Ka Yi Lian (01762), repurchasing 7.14 million shares for a total of 5.06 million yuan [1][2] - Other notable buybacks include Mengniu Dairy (02319) with 300,000 shares for 4.97 million yuan and China International Marine Containers (02039) with 613,100 shares for 4.03 million yuan [2] Group 2 - The cumulative buyback figures for the year show Wan Ka Yi Lian (01762) has repurchased a total of 17.37 million shares, representing 0.981% of its total share capital [2] - Other companies with significant cumulative buyback percentages include Kangchen Pharmaceutical (01681) at 5.926% and China Aluminum Can (06898) at 3.900% [2] - The buyback activity reflects a strategic move by these companies to enhance shareholder value and signal confidence in their financial health [1][2]

Core Viewpoint - The investment in the plush toy brand "Super Vitality Factory" by the reading group signifies a growing interest in the collectible toy market, driven by the success of Bubble Mart and the potential of IP development in this sector [1][3][5]. Group 1: Investment and Market Dynamics - "Super Vitality Factory" has secured a strategic investment from the reading group, acquiring a 10% stake, marking a significant event in the plush toy industry [1][3]. - The investment reflects a broader trend where major companies are rapidly entering the collectible toy market, following the success of Bubble Mart, which has a market capitalization exceeding 300 billion [5][12]. - The collectible toy market is increasingly seen as a new narrative driven by emotional value, with companies exploring various avenues such as AI companions and virtual stars [3][5]. Group 2: IP Development and Brand Strategy - The success of Bubble Mart is closely tied to its ability to create and manage IP, with a reported revenue of 13.038 billion in 2024, a year-on-year increase of 106.92% [5][12]. - The reading group, with its extensive IP resources, is positioned to leverage its existing content to enhance the collectible toy market, potentially creating a closed-loop system where toys activate consumer engagement [13][28]. - The competitive landscape is shifting towards IP creation, with companies like Lehua Entertainment and its WAKUKU brand aiming to replicate the success of Bubble Mart through strategic partnerships and celebrity endorsements [9][25]. Group 3: Future Trends and Challenges - The future of the collectible toy market may not follow a single path but will likely balance emotional resonance and long-term value, with various models emerging, including traditional IP development, AI-driven companionship, and content-based strategies [29][30]. - The challenge remains in effectively translating literary IP into appealing visual symbols for the younger demographic, ensuring that the products resonate with both fans and casual consumers [28][30]. - The evolving landscape suggests that the next successful brand will be one that can deeply connect with users, transcending mere collectibles to become meaningful emotional companions [29][30].